Skip to content

Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery

Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery: a Single-centre, Retrospective, Observational Study Based on Five Selected Randomised Controlled Trials

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04951752
Acronym
TQL_PACU
Enrollment
307
Registered
2021-07-07
Start date
2021-04-14
Completion date
2021-08-01
Last updated
2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local

Brief summary

The study will review data collected in 5 previously completed randomised controlled trials with a new primary outcome: to assess whether administration of the transmuscular quadratus lumborum block has an impact on the time an individual patient stays in the postanaesthesia care unit and how much opioid is consumed during this specified time.

Interventions

DRUGRopivacaine injection

Transmuscular quadratus lumborum block - active

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Elective Surgery

Exclusion criteria

* Inability to cooperate * Allergy to local anaesthetics or opioids * Inability to understand Danish * Regular intake of opioids * Local infection at site of injection

Design outcomes

Primary

MeasureTime frameDescription
Duration of recovery0-300 minutesMinutes from arrival in PACU to completed recovery (arrival until ready for departure)

Secondary

MeasureTime frameDescription
Duration of stay at PACU after completed recovery0-300 minutesMinutes from completed recovery to actual departure from PACU
Total time spent in recovery0-300 minutesMinutes from arrival in PACU to actual departure time (arrival until actual departure)
Total opioid consumption in PACU0-300 minutesTotal amount of opioid administered, converted to Oral Morphine Equivalents
Highest pain score in PACU0-300 minutesHighest reported Numeric Rating Scale of pain during stay in recovery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026